Navigation Links
New Data On Xeomin® (IncobotulinumtoxinA) To Be Presented At The 15th International Congress Of Parkinson's Disease And Movement Disorders (MDS)
Date:6/8/2011

01) in each group (using paired t-test).

About XEOMIN®

In nature, Clostridium botulinum produces the toxin in association with accessory (complexing) proteins. Manufacturers isolate the therapeutically active botulinum neurotoxin together with the accessory (complexing) proteins. XEOMIN (incobotulinumtoxinA) is manufactured using a proprietary process that isolates in an additional purification step the therapeutic component and eliminates accessory proteins.

More than 127,000 patients have been treated with XEOMIN worldwide since 2005. XEOMIN is approved in 21 countries worldwide for the treatment of cervical dystonia and blepharospasm and in 17 countries for the treatment post stroke upper limb spasticity. It is currently not approved in the U.S. for the treatment of spasticity.

XEOMIN is the only botulinum toxin product that does not require refrigeration prior to reconstitution.

Merz Pharmaceuticals GmbH (www.merz.com):

Merz Pharmaceuticals, a member of the MerzPharma Group of companies, is an innovative and international specialty healthcare company specializing in the research, development and marketing of pharmaceuticals for the treatment of neurological and psychiatric diseases. In addition to developing XEOMIN®, the company has developed memantine (Axura®) -- the first drug for the treatment of moderate to severe Alzheimer's disease. The company also focuses on the development of innovative therapies within the therapeutic areas of hepatology, metabolic disease and dermatology.

XEOMIN is a registered trademark of MerzPharma GmbH & Co KGaA.


'/>"/>
SOURCE Merz Pharmaceuticals
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. FDA Approves Merz Pharmaceuticals Xeomin® (incobotulinumtoxinA) for the Treatment of Cervical Dystonia and Blepharospasm
2. Xeomin® (incobotulinumtoxinA) - a Botulinum Toxin Free From Accessory Proteins - Now Available in the U.S.
3. Xeomin® (incobotulinumtoxinA) Data To Be Presented At The 71st Annual Assembly Of The American Academy Of Physical Medicine And Rehabilitation
4. Merz Pharmaceuticals Introduces Comprehensive Programs to Provide Patients With Financial Assistance for Xeomin® (incobotulinumtoxinA)
5. Merz Pharmaceuticals Announces New Centers for Medicare and Medicaid Billing Q-Code for Xeomin® (incobotulinumtoxinA)
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Pre-clinical Data on Recent Advances with HIV VLP Vaccine Presented at AIDS Vaccine 07 Conference
8. New Study Presented at WorldSleep 2007 Demonstrates Ramelteon Has Sustained Efficacy Over Six Months in Adults With Chronic Insomnia
9. Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology
10. Ozarelix Phase 2 Data Presented at 29th Congress of the Societe Internationale dUrologie
11. GeoVax Successful HIV/AIDS Vaccine Trial Data Presented at AIDS Vaccine 2007 Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... LEHIGH VALLEY, Pa. , July 7, 2015  Air ... efficiency of its medical oxygen supply systems—including high efficiency systems ... the 52 nd ASHE Annual Conference and Technical Exhibition ... ASHE attendees are invited to stop by ... help reduce their oxygen usage by as much as 30 ...
(Date:7/7/2015)... , June 30, 2015 ... of the "Outlook of Global Biologic Drug Discovery ... The global biologic drug discovery outsourcing market will likely ... 2020, and may reach $11.4 B by 2020. ... biologics (or biopharmaceuticals) have become a new but important ...
(Date:7/7/2015)... , July 7, 2015 Biobanks ... Helping Your Influence  ,Are you interested ... so, now gain technological and commercial predictions from 2015. ... explore trends in research and development, results, opportunities and ... visiongain shows you what,s possible for biobanking and ...
Breaking Medicine Technology:Air Products Highlights Reliability and Efficiency of Its Medical Oxygen Supply Systems at ASHE Conference and Exhibition 2Outlook of Global Biologic Drug Discovery Outsourcing Market to 2020 2Outlook of Global Biologic Drug Discovery Outsourcing Market to 2020 3Biobanking for Medicine: Technology, Industry and Market 2015-2025 2Biobanking for Medicine: Technology, Industry and Market 2015-2025 3Biobanking for Medicine: Technology, Industry and Market 2015-2025 4Biobanking for Medicine: Technology, Industry and Market 2015-2025 5Biobanking for Medicine: Technology, Industry and Market 2015-2025 6Biobanking for Medicine: Technology, Industry and Market 2015-2025 7Biobanking for Medicine: Technology, Industry and Market 2015-2025 8Biobanking for Medicine: Technology, Industry and Market 2015-2025 9Biobanking for Medicine: Technology, Industry and Market 2015-2025 10
(Date:7/7/2015)... ... 2015 , ... This week Northeast Nebraska Imaging, Norfolk’s leading ... website’s goal is to provide patients with detailed information about the various aspects ... online. , Part of the center’s rebranding efforts, the website was designed specifically ...
(Date:7/7/2015)... ... July 07, 2015 , ... Celestix ... CelestixEdge VE and CelestixFederated VA Series virtual appliances. These virtual platforms expand ... of products, which have proven to simplify the on-premises deployment of unified remote ...
(Date:7/7/2015)... ... ... June Pacific Prime Renewals team in Hong Kong announced that they were taking the ... Cotton, aims to not only reduce but eventually eliminate the use of paper in the ... 300 and 600 pieces of paper per month. Not to mention A4 sized envelopes used ...
(Date:7/7/2015)... ... July 07, 2015 , ... On Saturday, May 16th, 2015, the ... Manistee Golf and Country Club. Best Drug Rehabilitation staff members were delighted to join ... underprivileged children. Kiwanis International, the parent of the Manistee Kiwanis Club, is a global ...
(Date:7/7/2015)... ... 07, 2015 , ... With a new community program in the San Antonio, ... announced a new charity campaign to raise funds in support of programs for veterans. ... was created especially to care for the special needs of our soldiers. Clear ...
Breaking Medicine News(10 mins):Health News:Northeast Nebraska Imaging Launches New Patient Friendly Website 2Health News:Celestix Now Offers Virtual Editions of Its Unified Remote Access and SSO Platforms to Enable Easy Deployment in Virtualized Environments 2Health News:Celestix Now Offers Virtual Editions of Its Unified Remote Access and SSO Platforms to Enable Easy Deployment in Virtualized Environments 3Health News:Celestix Now Offers Virtual Editions of Its Unified Remote Access and SSO Platforms to Enable Easy Deployment in Virtualized Environments 4Health News:Pacific Prime Hong Kong Renewals Team Starts Push to go Green 2Health News:Best Drug Rehabilitation Team Participates in Kiwanis Club Golf Outing Fundraiser 2Health News:Clear Insurance Group and Nonprofit Soldiers’ Angels Initiate New Charity Campaign in San Antonio, TX to Provide Aid and Comfort for Veterans 2Health News:Clear Insurance Group and Nonprofit Soldiers’ Angels Initiate New Charity Campaign in San Antonio, TX to Provide Aid and Comfort for Veterans 3
... test, developed by a UCSF team, gives patients and ... and pinpointing high risk cases. According to UCSF ... in predicting bone metastasis, prostate cancer-specific mortality, and all-cause ... test is known as the UCSF Cancer of the ...
... results from the second series of trials have demonstrated a ... log reduction (99.994%) in Methicillin Resistant Staph Aureus (MRSA). Both ... facilities world wide with the spread of MRSA infection often ... (JAMA 2007) that MRSA alone is now associated with an ...
... attributable to Nancy H. Nielsen, M.D., President, American Medical Association: ... ) , , "Today, the American Medical Association ... at our annual meeting. Like President Obama, the AMA is ... with affordable, high-quality health coverage. , , "The AMA ...
... Finn, Jr., C.P.A. ("Finn") announced today that in vitro studies have ... Galectin-3 plays an important role in tumor cell survival, new ... spread of cancer beyond its primary site. As a result, ... including: , , , , ...
... is to foster open collaboration between Lilly and global laboratory ... Alzheimer,s disease. Cancer. Diabetes. Osteoporosis. , , These ... be engaging researchers from around the world in a new ... called the Lilly Phenotypic Drug Discovery Initiative, or PD2 (pronounced ...
... Survey , , LOS ANGELES, June 15 Skin ... United States, so why did 60% of American adults ... NEUTROGENA (R) , the #1 dermatologist recommended ... habits and behavior. The results, released today, reveal that ...
Cached Medicine News:Health News:Prostate cancer test improves prediction of disease course 2Health News:Prostate cancer test improves prediction of disease course 3Health News:Medizone Announces That Its AsepticSure(TM) Development Program is Reaching Objectives on Two Fronts 2Health News:AMA Committed to Health Reform, Welcomes President Obama 2Health News:Prospect Therapeutics' In Vitro Studies Demonstrate that GCS-100 Drug Binds to and Blocks the Effects of Galectin-3 2Health News:Eli Lilly and Company Announces New Drug Discovery Initiative 2Health News:Eli Lilly and Company Announces New Drug Discovery Initiative 3Health News:Eli Lilly and Company Announces New Drug Discovery Initiative 4Health News:While the Dangers of Sun Exposure are Widely Understood Americans Fall Short of Adequately Protecting Themselves from the Sun 2Health News:While the Dangers of Sun Exposure are Widely Understood Americans Fall Short of Adequately Protecting Themselves from the Sun 3Health News:While the Dangers of Sun Exposure are Widely Understood Americans Fall Short of Adequately Protecting Themselves from the Sun 4
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: